Allena Pharmaceuticals, Inc.

ALNAQ · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$32,845-$32,845-$47,339-$35,648
Dep. & Amort.$363$166$163$78
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,671$4,051$2,989$2,049
Change in WC-$1,483-$159$61$904
Other Non-Cash-$15,384$628$494$778
Operating Cash Flow-$45,678-$28,159-$43,632-$31,839
Investing Activities
PP&E Inv.-$667-$650-$122-$318
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$18$0$0
Investing Cash Flow-$667-$632-$122-$318
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$41,273$33,995$0$34
Stock Repurch.$0$0$0-$309
Dividends Paid$0$0$0$0
Other Fin. Act.$41,291$33,826$12,118-$694
Financing Cash Flow$41,291$33,826$12,118-$694
Forex Effect$0$0$0$0
Net Chg. in Cash-$5,054$5,035-$31,636-$32,851
Supplemental Information
Beg. Cash$35,042$30,007$61,643$94,494
End Cash$29,988$35,042$30,007$61,643
Free Cash Flow-$46,345-$28,809-$43,754-$32,157